← SynDRA
LOPERAMIDE
SynDRA canonical compound SYN0002153 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | OPRM1 |
|---|
| Mechanism of action | Opioid receptor agonist |
|---|
| Indication | diarrhea |
|---|
| Disease area | gastroenterology |
|---|
All known targets
- OPRM1
- OPRD1
- CACNA1A
- OPRK1
- CALM1
- ADRA1D
- Pgrmc1
- MEN1
- NPR2
- Oprd1
- Oprm1
- POMC
Mechanisms of action (all sources)
- Opioid receptor agonist
- OPRM1 AGONIST
- Mu opioid receptor agonist
- OPRD1 BINDER
Drug classes
- Opioid Agonists
- Antidiarrheals
- Gastrointestinal Agents
- Opioid Agonist
ATC classes
Cross-references
Synonyms
- loperamide hydrochloride
- imodium
- loperamide HCl
- Loperamida
- Ioperamide
- Loperacap
- Loperamidum
- Kaopectate II
- Loperamide Monohydrochloride
- Pepto Diarrhea Control
- Apo-Loperamide
- Diamide (TN)
- Diarr-Eze
- Dimor (TN)
- Imodium (TN)
- Imodium A-D Caplets
- Loperamida [INN-Spanish]
- Loperamide (INN)
- Loperamide [INN:BAN]
- Loperamidum [INN-Latin]
- Lopex (TN)
- Maalox Anti-Diarrheal
- Nu-Loperamide
- PMS-Loperamide
- Pepto (TN)
- R-18553
- Rho-Loperamide
- loperamide oxide monohydrate impurity a (ep impurity)
- 6X9OC3H4II
- Fortasec
- CHEBI:6532
- DTXCID4025165
- NSC696356
- RefChem:5959
- NCGC00015608-04
- A1CMV
- LOPERAMIDE [INN]
- CAS-53179-11-6
Reported adverse events
- Rash
- Constipation
- Urinary retention
- Dizziness
- Dry mouth
- Nausea
- Stevens-Johnson syndrome
- Gastrointestinal disorder
Look up LOPERAMIDE in the interactive SynDRA portal →